Kratom and 7-OH: A Family Guide to Dependence, Withdrawal, and Treatment

Kratom does not look like a drug of abuse. It comes in a paper bag from a smoke shop, or a capsule bottle on a gas-station shelf, or a brightly colored shot at the register, or an order that arrives in the mail. It is legal almost everywhere, sold as an herbal supplement, and promoted online as a natural way to manage pain, anxiety, and even withdrawal from opioids.

That is exactly what makes it hard for families to see. Kratom is not a scam or a placebo — the plant's compounds act on the same receptor in the brain that opioid painkillers do, and a growing number of people who used kratom casually discover they cannot stop without feeling sick. This guide is for the family member watching that happen: what kratom actually does, why the modern product line is not the same thing your neighbor brewed as tea, what withdrawal looks like, and how treatment works when someone is ready.

Why a "natural" supplement deserves a second look

Every few weeks, a state health department issues a new warning about a kratom product. In the last several weeks alone, officials in Utah, Missouri, and Florida have all warned about products sold as kratom — or mislabeled as a harmless botanical called cat's claw — that actually contained synthetic opioid compounds. We covered those warnings in our Utah alert, our Missouri alert, and our federal scheduling alert.

Those headlines are about the supply. This guide is about the person: the family member who started with a legal product from a store shelf and now needs help.

What kratom actually is

"Kratom" is both a tree — Mitragyna speciosa, native to Southeast Asia — and the products made from its leaves, which are sold as dietary supplements in the United States. The leaves contain dozens of compounds called alkaloids, and two of them matter most: mitragynine and 7-hydroxymitragynine, usually shortened to 7-OH.

Mitragynine, 7-OH, and the opioid receptor

Both compounds activate the mu-opioid receptor — the same molecular target that heroin, oxycodone, and fentanyl act on, and the same one the medication buprenorphine acts on. That shared target is why kratom can genuinely ease pain and, for some people, genuinely ease opioid withdrawal. It is also why kratom can produce dependence, tolerance, and a withdrawal syndrome that looks a great deal like opioid withdrawal.

Two details explain why 7-OH has become the focus of federal regulators and state health officials:

• When you swallow kratom leaf or powder, your body converts some of the mitragynine into 7-OH. That conversion happens slowly enough that mitragynine's effect on breathing is limited.
• 7-OH on its own is a different story. In laboratory models, 7-OH can cause respiratory depression — slowed, shallow breathing — and that effect is reversed by naloxone, the same medication that reverses an opioid overdose.

In other words: the plain leaf a person brews as tea and the concentrated, isolated 7-OH sold in gummies, shots, and tablets is not the same drug at the same risk level. That distinction sits at the center of almost every recent warning.

Why two products with the same label can be completely different drugs

Because kratom is sold as a supplement rather than a medicine, there is no standardized dose, no required purity testing, and no guarantee about what is actually in the package. Research documents the result:

• Potency varies enormously from product to product, and effects depend on the amount, the concentration, the formulation, and the way it is taken.
• Some products have been found to contain contaminants that produce effects not associated with kratom compounds at all.
• A 2026 survey of more than 11,000 US adults found the most common kratom products were pills, gummies, and powders — and that the reported rate of adverse effects climbed as the amount per dose increased.
• The researchers' conclusion is blunt: the lack of standardization and consistency in kratom products results in unpredictable effects.

So a person who says "the last batch was fine" is describing a coincidence, not a guarantee. A different package from the same shelf can be a different drug.

How kratom dependence develops

Here is the part families most often miss: kratom dependence is not rare, and it is not limited to people who were already using other drugs. Thousands of people — many of whom started kratom specifically to avoid opioids — end up physically dependent on it.

The pattern is familiar to anyone who knows opioid dependence. A person takes kratom daily for pain, for energy, for anxiety, or to feel normal. Over weeks and months, the same amount stops working, so they take more. Then they notice that skipping a day feels awful. Then they notice they are taking it not to feel good but to avoid feeling bad.

The DSM-5 picture

Clinicians diagnose substance use disorders using the DSM-5, and researchers applying those criteria specifically to kratom have described how kratom use disorder usually presents. People who meet the criteria typically do so through:

• Tolerance — needing more to get the same effect.
• Withdrawal — feeling physically and mentally unwell when they stop.
• Using more than intended, and for longer than intended.
• Craving.

Notably, the criteria that describe functional collapse — losing jobs, relationships, or obligations — are encountered much less often in isolated kratom use disorder than in other substance use disorders. That is a trap for families: a person can be dependent on kratom while still holding down a job, a marriage, and a normal-looking life. Functioning is not the same as not being dependent.

Why the "it's just a plant" argument breaks down

The plant argument confuses source with effect. Morphine comes from a plant. So does nicotine. What determines whether a substance can cause dependence is what it does in the brain, not how it was grown. Mitragynine and 7-OH both partially activate the mu-opioid receptor — which is the mechanism by which opioids produce dependence — and that is enough.

What kratom withdrawal feels like

Because kratom dependence is under-studied, many people are caught off guard by how uncomfortable stopping is. Researchers reviewing the clinical literature describe a withdrawal syndrome that is generally mild to moderate — usually less severe than acute opioid withdrawal, but clearly real, and for heavy users it can be genuinely disabling for a period of days to weeks.

Psychological symptoms commonly reported:

• Depressed mood
• Anxiety and a feeling of tension
• Restlessness
• Irritability

Physical symptoms commonly reported:

• Muscle aches and body aches, joint pain
• Insomnia
• Runny nose and watery eyes
• Yawning
• Diarrhea
• Loss of appetite
• Chills and a feverish sensation
• Tremors
• Itching
• Trouble concentrating

Two things follow from this list. First, if your family member has tried to quit kratom and "felt like they had the flu" for a week, that was almost certainly withdrawal — not a coincidental illness. Second, the withdrawal itself is a reason not to stop abruptly without support, particularly for someone using large amounts daily. A planned, medically informed taper or a supervised transition onto medication is far kinder and far more likely to hold.

The dangers families most often miss

1. Breathing risk with 7-OH

The classic opioid danger — slowed breathing — appears to be limited with plain leaf and mitragynine. It is a real concern with concentrated 7-OH, which in laboratory models produces respiratory depression that naloxone reverses. This means two practical rules for any household where someone uses kratom concentrates:

• Keep naloxone in the house and know how to use it. Naloxone cannot harm someone who is not overdosing. If you are unsure where to get it, see our naloxone guide.
• Call 911 at the first sign of an emergency — unresponsiveness, slow or stopped breathing, gurgling, blue or gray lips and fingertips.

2. Mislabeled and adulterated products

The most dangerous products are often the ones whose labels are the most reassuring. Recent state warnings have involved products labeled as a benign botanical (cat's claw) that actually contained synthetic kratom compounds, and products marketed as kratom that tested positive for synthetic opioids. Assume that a non-pharmacy product promising a strong psychoactive effect may not contain what the label says.

3. Mixing with other substances

Studies suggest many people who use kratom also use other drugs, and case reports describe severe outcomes — including liver problems and death — when kratom is combined with other substances. Alcohol, benzodiazepines, and opioids are the combinations of greatest concern, because they stack sedation and breathing suppression.

4. Pregnancy

Very little research exists on kratom in pregnancy, but there are reported cases of neonatal abstinence syndrome — opioid-like withdrawal in a newborn — in infants born to women who regularly used kratom. If someone is pregnant or trying to become pregnant and using kratom regularly, this belongs in the first conversation with their obstetric provider.

5. Impairment

The effects of kratom intoxication on driving, operating machinery, and other safety-sensitive tasks have not been well studied. "Not well studied" is not the same as "safe." Treat kratom the way you would treat any centrally acting drug when it comes to driving.

What the law says right now

The legal picture is shifting faster than most families realize.

• The FDA has not approved kratom or any kratom compound for any medical use. It is available as a supplement, not a medicine — which is precisely why purity and dosing are not guaranteed.
• The DEA temporarily placed three synthetic kratom compounds — mitragynine pseudoindoxyl, MGM-15, and MGM-16 — in Schedule I, effective August 26, 2026 through August 26, 2028, on an "imminent hazard to public safety" finding. Those are the compounds identified in several recent state product warnings.
• The DEA has also proposed placing 7-hydroxymitragynine above a specified threshold in Schedule I, with the comment period extended in August 2026. That proposal targets concentrated, manufactured 7-OH — not the botanical leaf.

State law is a patchwork: some states restrict or ban kratom products outright, some limit sales to adults 21 and over, and some regulate only the synthetic compounds. If the legality of a specific product matters to your family's situation, check your own state health or agriculture department — and do not assume that "legal" means "safe," or that "banned" means "gone."

How kratom dependence is treated

This is the section families need most, and it comes with honest caveats as well as real hope.

Medication

There is currently no medication approved by the FDA specifically for kratom withdrawal or kratom use disorder, and robust clinical trials are still needed. But that does not mean there is nothing to offer.

• Buprenorphine — the same medication used to treat opioid use disorder — is the treatment most clinicians reach for in kratom dependence. A published case series and systematic literature review found a strong relationship between how much kratom a person used daily and how much buprenorphine was needed to stabilize them, and proposed starting ranges of roughly 4/1–8/2 mg per day for people using under 20 g of kratom daily, and 12/3–16/4 mg per day for those using over 40 g daily.
• The 2024 clinical review on kratom use disorder is candid: most clinicians who use medication for isolated kratom use disorder choose buprenorphine formulations, but there are no controlled studies yet proving safety and efficacy in this specific population. The reviewers recommend a systematic approach that first asks whether the person also has opioid use disorder — because if they do, the evidence base for treatment is much stronger, and standard opioid use disorder care applies.
• Naloxone is not a treatment for dependence; it is the emergency reversal medication for an overdose (and, as noted above, it works against 7-OH respiratory depression).

If your family member is being told to "just taper" with no medical support, it is reasonable to ask a clinician specifically about buprenorphine. More on medication for substance use disorder in our MAT guide.

Therapy and levels of care

Medication, where used, works best alongside behavioral treatment. The same therapies that help with other substance use disorders apply: cognitive behavioral therapy, contingency management, motivational enhancement, and family-based therapy. Because kratom is frequently used to self-treat something else — chronic pain, anxiety, depression, insomnia — a good assessment looks for and treats those too, rather than treating kratom in isolation.

For people whose daily use is heavy and whose withdrawal is severe, supervised withdrawal management (detox) followed by ongoing treatment is often the safest path. Our guides on detox and withdrawal management and choosing a treatment center walk through what to expect and what to ask.

If someone is in immediate danger

Do not wait for a treatment appointment. Give naloxone if you have it, call 911, stay with the person, and keep them on their side. Our guide on what to do in the first 72 hours after an overdose covers the hours that follow.

How to talk to your family member about kratom

Families often get this wrong for a completely understandable reason: kratom is legal, so the conversation feels like it has no footing.

• Lead with concern, not the label. "I've noticed you get shaky and irritable when you miss a dose, and I'm worried" lands better than "You're addicted to gas-station drugs."
• Describe what you see, not what you conclude. The withdrawal symptoms listed above are things a family can observe and name without diagnosing.
• Bring information, not a verdict. "There's no approved medication for kratom, and the products vary a lot — I'd like us to talk to a doctor who understands this" is a request, not an accusation.
• Separate the person from the substance. Dependence is a medical condition, not a character flaw.
• Skip the ambush. A family tribunal at the kitchen table, or a lecture delivered in the first five minutes, usually produces defensiveness. If you are considering a structured intervention, our intervention guide explains how to do it in a way that keeps the door open.

And if the person is not ready: our guide on supporting a loved one who refuses treatment is written for exactly that moment.

Where to get help

• SAMHSA National Helpline: 1-800-662-4357 — free, confidential, 24/7 treatment referral and information, in English and Spanish.
• FindTreatment.gov — search for treatment by ZIP code, insurance status, and type of care.
• 988 Suicide & Crisis Lifeline — call or text 988 for mental health crisis support.
• Poison Control: 1-800-222-1222 — free, confidential, 24/7, for questions about a specific product or exposure.
• 911 — for any suspected overdose or breathing emergency.

The bottom line

Kratom is not a harmless herbal supplement, and 7-OH is not a mild version of it. Both act on the opioid receptor; both can produce genuine dependence; and the modern product line is variable enough that a person cannot know from the label what they are taking. The good news is that the same clinical infrastructure that treats opioid use disorder — medication, behavioral therapy, supervised withdrawal, ongoing care — is available to people who are dependent on kratom, and clinicians are increasingly familiar with it.

If you are the family member in this story, the most useful thing you can do today is small and specific: get naloxone into the house, learn the signs of an emergency, and start one non-accusatory conversation. Then, when the person is ready, help them find a clinician who takes kratom dependence seriously. That combination — safety first, then treatment — is how most families get their person back.